DE69736644D1 - Verfahren zur Vorbeugung von Brustkrebs durch Verabreichung von Raloxifen - Google Patents

Verfahren zur Vorbeugung von Brustkrebs durch Verabreichung von Raloxifen

Info

Publication number
DE69736644D1
DE69736644D1 DE69736644T DE69736644T DE69736644D1 DE 69736644 D1 DE69736644 D1 DE 69736644D1 DE 69736644 T DE69736644 T DE 69736644T DE 69736644 T DE69736644 T DE 69736644T DE 69736644 D1 DE69736644 D1 DE 69736644D1
Authority
DE
Germany
Prior art keywords
raloxifene
administration
prevention
breast cancer
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69736644T
Other languages
English (en)
Other versions
DE69736644T2 (de
Inventor
Fredric Jay Cohen
Joan Ellen Glusman
Ronald Keith Knickerbocker
Nikolaus Thomas Nickelsen
Teri Janine Scott
Robert Stephen Eckert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69736644(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69736644D1 publication Critical patent/DE69736644D1/de
Publication of DE69736644T2 publication Critical patent/DE69736644T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69736644T 1996-10-30 1997-10-29 Verfahren zur Vorbeugung von Brustkrebs durch Verabreichung von Raloxifen Expired - Lifetime DE69736644T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
US29850P 1996-10-30
GB9624800 1996-11-29
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10
US40260P 1997-09-10

Publications (2)

Publication Number Publication Date
DE69736644D1 true DE69736644D1 (de) 2006-10-19
DE69736644T2 DE69736644T2 (de) 2007-10-25

Family

ID=27268608

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69736644T Expired - Lifetime DE69736644T2 (de) 1996-10-30 1997-10-29 Verfahren zur Vorbeugung von Brustkrebs durch Verabreichung von Raloxifen
DE69721692T Expired - Fee Related DE69721692T2 (de) 1996-10-30 1997-10-29 Verbesserung in oder in Bezug auf der Vorbeugung von Brustkrebs durch Verabreichung von Raloxifen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69721692T Expired - Fee Related DE69721692T2 (de) 1996-10-30 1997-10-29 Verbesserung in oder in Bezug auf der Vorbeugung von Brustkrebs durch Verabreichung von Raloxifen

Country Status (44)

Country Link
US (2) US6303634B1 (de)
EP (3) EP1369115B1 (de)
JP (2) JPH10147529A (de)
CN (2) CN1182590A (de)
AP (1) AP971A (de)
AR (2) AR013864A1 (de)
AT (2) ATE239475T1 (de)
AU (3) AU5005697A (de)
BE (2) BE1011382A5 (de)
BG (1) BG63841B1 (de)
BR (1) BR9712703A (de)
CA (2) CA2219377A1 (de)
CH (2) CH693820A5 (de)
CZ (2) CZ300261B6 (de)
DE (2) DE69736644T2 (de)
DK (2) DK0839532T3 (de)
EA (2) EA002054B1 (de)
EE (1) EE03663B1 (de)
ES (4) ES2135342B1 (de)
FR (2) FR2756490B1 (de)
GB (3) GB2318733A (de)
GE (1) GEP20032910B (de)
GR (2) GR970100409A (de)
HK (1) HK1010495A1 (de)
HU (2) HUP9701778A3 (de)
IE (2) IE970772A1 (de)
IL (2) IL122026A0 (de)
IS (1) IS5035A (de)
IT (2) IT1298470B1 (de)
LU (2) LU90157B1 (de)
LV (1) LV12353B (de)
MY (1) MY121623A (de)
NL (2) NL1007386C2 (de)
NO (2) NO322468B1 (de)
NZ (1) NZ329042A (de)
PT (2) PT1369115E (de)
RO (1) RO120813B1 (de)
SG (2) SG72765A1 (de)
SI (3) SI20107A (de)
SK (1) SK287047B6 (de)
TR (1) TR199900951T2 (de)
UA (1) UA46762C2 (de)
WO (2) WO1998018449A1 (de)
YU (1) YU42397A (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
JP2004531559A (ja) 2001-05-22 2004-10-14 イーライ・リリー・アンド・カンパニー エストロゲン欠乏または内因性エストロゲンに対する異常な生理反応に関連する疾患を抑制するためのテトラヒドロキノリン誘導体
WO2002094788A1 (en) 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US20040225200A1 (en) * 2003-05-09 2004-11-11 Edmundson Catherine M. System and method of analyzing the health of a population
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CN102973573B (zh) * 2012-11-28 2015-04-08 玉林师范学院 一种人乳腺癌细胞抑制剂及制备方法
CN103830197A (zh) * 2014-03-14 2014-06-04 崔书豪 一种盐酸雷洛昔芬分散片及其制备方法
CN116650484A (zh) * 2023-05-11 2023-08-29 南通大学 一种乳腺癌相关蛋白的抑制剂及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
HUT71237A (en) * 1993-10-15 1995-11-28 Lilly Co Eli Pharmaceutical compositions for treating resistant neoplasms containing 2-phenyl-3-aroil-benzotiophene derivatives and process for their preparation
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
ZA951497B (en) * 1994-03-02 1996-08-23 Lilly Co Eli Orally administerable pharmaceutical formulations
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
US5821254A (en) 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
IL140742A (en) * 1996-03-26 2012-02-29 Lilly Co Eli Reloxifen and pharmaceuticals containing it

Also Published As

Publication number Publication date
AP971A (en) 2001-05-30
ES2135343A1 (es) 1999-10-16
GB9911557D0 (en) 1999-07-21
IL122026A0 (en) 1998-03-10
AU4364797A (en) 1998-05-07
EA200100716A1 (ru) 2002-06-27
ES2271476T3 (es) 2007-04-16
LV12353A (lv) 1999-10-20
GR1003189B (el) 1999-09-01
ES2135342A1 (es) 1999-10-16
PT839532E (pt) 2003-09-30
LU90157B1 (fr) 1998-06-02
DK0839532T3 (da) 2003-08-25
MX9708341A (es) 1998-08-30
BR9712703A (pt) 1999-10-26
AU5005197A (en) 1998-05-22
AP9901494A0 (en) 1999-03-31
LU90158B1 (fr) 1998-06-02
MX9708340A (es) 1998-08-30
CA2219070A1 (en) 1998-04-30
BG103369A (en) 2000-05-31
FR2755014B1 (fr) 1999-02-05
CH691847A5 (fr) 2001-11-15
LV12353B (en) 2000-02-20
EP0839533A1 (de) 1998-05-06
SK55999A3 (en) 2000-06-12
GEP20032910B (en) 2003-03-25
EP1369115B1 (de) 2006-09-06
ATE338551T1 (de) 2006-09-15
ES2135342B1 (es) 2000-05-16
SK287047B6 (sk) 2009-10-07
IE970773A1 (en) 2000-02-09
HUP9701777A3 (en) 1999-07-28
IS5035A (is) 1999-04-27
AU4364897A (en) 1998-05-07
IL122025A0 (en) 1998-03-10
GR970100409A (el) 1998-06-30
CA2219377A1 (en) 1998-04-30
CN1182591A (zh) 1998-05-27
EA002054B1 (ru) 2001-12-24
NO974973D0 (no) 1997-10-28
ES2197312T3 (es) 2004-01-01
NO322468B1 (no) 2006-10-09
EP0839532B1 (de) 2003-05-07
GR970100408A (el) 1998-06-30
SG83672A1 (en) 2001-10-16
DE69721692D1 (de) 2003-06-12
SI20107A (sl) 2000-06-30
GB9722796D0 (en) 1997-12-24
HUP9701778A3 (en) 1999-06-28
CZ341297A3 (cs) 1998-05-13
NO974972L (no) 1998-05-04
CZ300261B6 (cs) 2009-04-01
MY121623A (en) 2006-02-28
NO974972D0 (no) 1997-10-28
FR2756490A1 (fr) 1998-06-05
EE9900162A (et) 1999-12-15
GB2318734A (en) 1998-05-06
EE03663B1 (et) 2002-04-15
HUP9701777A2 (hu) 1999-06-28
AR013864A1 (es) 2001-01-31
GB2318734B (en) 1999-12-01
PT1369115E (pt) 2006-12-29
DE69736644T2 (de) 2007-10-25
BE1011382A5 (fr) 1999-08-03
WO1998018325A1 (en) 1998-05-07
ITMI972433A1 (it) 1999-04-29
EP0839532A1 (de) 1998-05-06
YU42397A (sh) 2000-10-30
AU5005697A (en) 1998-05-22
UA46762C2 (uk) 2002-06-17
FR2755014A1 (fr) 1998-04-30
SI0839532T1 (en) 2003-10-31
GB9722801D0 (en) 1997-12-24
ITMI972434A1 (it) 1999-04-29
IL122025A (en) 2003-01-12
CZ341197A3 (cs) 1998-05-13
NL1007387C2 (nl) 1998-05-14
AU731388B2 (en) 2001-03-29
EA006083B1 (ru) 2005-08-25
US6303634B1 (en) 2001-10-16
FR2756490B1 (fr) 2003-06-20
DE69721692T2 (de) 2004-03-25
SI1369115T1 (sl) 2006-12-31
IE970772A1 (en) 2000-02-09
CH693820A5 (fr) 2004-02-27
CA2219070C (en) 2007-12-18
ATE239475T1 (de) 2003-05-15
TR199900951T2 (xx) 1999-07-21
BG63841B1 (bg) 2003-03-31
US20020019418A1 (en) 2002-02-14
CN1182590A (zh) 1998-05-27
GB2318733A (en) 1998-05-06
EP1369115A1 (de) 2003-12-10
JPH10147529A (ja) 1998-06-02
NZ329042A (en) 1999-08-30
JPH10147530A (ja) 1998-06-02
RO120813B1 (ro) 2006-08-30
AR010538A1 (es) 2000-06-28
BE1011381A5 (fr) 1999-08-03
IT1298470B1 (it) 2000-01-10
DK1369115T3 (da) 2007-01-02
HU9701777D0 (en) 1997-12-29
HU9701778D0 (en) 1997-12-29
HUP9701778A2 (hu) 1999-01-28
HK1010495A1 (en) 1999-06-25
SG72765A1 (en) 2000-05-23
WO1998018449A1 (en) 1998-05-07
EA199900431A1 (ru) 1999-10-28
NL1007386C2 (nl) 1998-05-14

Similar Documents

Publication Publication Date Title
DE69736644D1 (de) Verfahren zur Vorbeugung von Brustkrebs durch Verabreichung von Raloxifen
DE69420250D1 (de) Verbessertes verfahren zur nachhallunterdrückung
DE69500662T2 (de) Verfahren zur Herstellung von Bisphenolen
DE69505796D1 (de) Verfahren zur fleischentfettung
DE59305971D1 (de) Verfahren zur entölung von rohlecithin
DE69515241T2 (de) Verfahren zur Emulsions-Polymerisation
DE69100197D1 (de) Verfahren zur verhinderung von hydraten.
DE69733883D1 (de) Verfahren zur zugabe von borverbindungen
DE69526796D1 (de) Verfahren zur inhibierung von pflanzenkrankheiten
DE69428364T2 (de) Verfahren zur brandbekämpfung
DE69529343D1 (de) Verfahren zur isolierung von mesophasepech
DE69129908D1 (de) Verfahren zur helligkeitsverbesserung
DE69511442D1 (de) Verfahren zur Herstellung von Polyorganosilan
DE68909447D1 (de) Verfahren zur molluskenbekaempfung.
DE69708707D1 (de) Verfahren zur Wiedergewinnung von Bisphenolen
DE59602234D1 (de) Verfahren zur Auftrennung von Alkylglycosiden
DE69732188D1 (de) Verfahren zur immununterdrückung
DE69026611T2 (de) Verfahren zur Bestimmung von Fruktosaminen
IDP000008233A (id) Metode pencegahan kanker payudara
DE59605044D1 (de) Verfahren zur Herstellung von Alkylhalogeniden
DE59508333D1 (de) Verfahren zur Isolierung von Tetraphenylboraten
DE58901714D1 (de) Verfahren zur verbesserung des nordungsergebnisses.
DE59407937D1 (de) Verfahren zur Momentanfrequenz-Detektion
DE69007027T2 (de) Verfahren zur abwasserbehandlung.
DE69614477T2 (de) Verfahren zur acyclierung von aromatischen ethern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN